Literature DB >> 6155332

Serology and energetics of cross-reactions among the H3 antigens of influenza viruses.

P A Underwood.   

Abstract

Reciprocal hemagglutination inhibition titrations were carried out with viruses and antisera of eight field strains of the A3 subtype of influenza A, covering the period from 1968 to 1975. The earlier strains (1968 through 1972) showed asymmetric cross-reactions, with antisera exhibiting more cross-reactions with antecedent strains than with subsequent ones. The later strains, although all were asymmetrically cross-reactive with earlier strains, tended to exhibit distant and variable cross-reactions with each other. The numbers and average affinities of antibody molecules capable of taking part in cross-reactions were calculated from equilibrium filtration experiments. It was found that all the antibody molecules in sera raised against the late strains could combine with earlier viruses, but with reduced affinity. Conversely, only a subset of the antibody molecules in sera raised against early strains could combine with later viruses. The results are discussed in the light of different theories concerning the nature and number of antigenic determinants on the hemagglutinin molecule. They support the existence of a single antigenic area to which all antibody molecules are directed, with differing affinities, rather than the existence of both "common" and "specific" determinants. Thermodynamic measurements on the homologous antigen-antibody reactions indicated that combination was mostly entropy driven. This suggested hydrophobic interaction as the mechanism of combination, i.e., that the complementary regions of antigen and antibody were made up largely or entirely of amino acids with hydrophobic side chains. There was no statistical difference in the magnitude of the entropy term (i.e., the average firmness of binding) among the different virus strains.

Mesh:

Substances:

Year:  1980        PMID: 6155332      PMCID: PMC550778          DOI: 10.1128/iai.27.2.397-404.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains.

Authors:  W G Laver; J C Downie; R G Webster
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

Review 2.  Evolution and hierarchy of influenza viruses.

Authors: 
Journal:  Arch Environ Health       Date:  1970-09

3.  New criteria for the selection of influenza vaccine strains.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Estimation of the number of surface projections on myxo- and paramyxoviruses.

Authors:  J M Tiffany; H A Blough
Journal:  Virology       Date:  1970-06       Impact factor: 3.616

5.  Studies with antibody to the purified haemagglutinin of an influenza Ao virus.

Authors:  G C Schild
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

6.  The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions. Establishment of a hydrophobicity scale.

Authors:  Y Nozaki; C Tanford
Journal:  J Biol Chem       Date:  1971-04-10       Impact factor: 5.157

7.  A quantitative, single-radial-diffusion test for immunological studies with influenza virus.

Authors:  G C Schild; M Henry-Aymard; H G Pereira
Journal:  J Gen Virol       Date:  1972-08       Impact factor: 3.891

8.  The structure of influenza viruses. IV. Chemical studies of the host antigen.

Authors:  W G Laver; R G Webster
Journal:  Virology       Date:  1966-09       Impact factor: 3.616

9.  Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus.

Authors:  J L Schulman; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

10.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory.

Authors:  J L Virelizier; R Postlethwaite; G C Schild; A C Allison
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  7 in total

1.  Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.

Authors:  Yang Li; David L Bostick; Colleen B Sullivan; Jaclyn L Myers; Sara B Griesemer; Kirsten Stgeorge; Joshua B Plotkin; Scott E Hensley
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

2.  Conservation and variation in the hemagglutinins of Hong Kong subtype influenza viruses during antigenic drift.

Authors:  G W Both; M J Sleigh
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

3.  Killer T cell responses to influenza A during a drift period: studies in mice.

Authors:  D Armerding; H Rossiter; E Liehl
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

4.  Consequences of host heterogeneity, epitope immunodominance, and immune breadth for strain competition.

Authors:  Sarah Cobey; Mercedes Pascual
Journal:  J Theor Biol       Date:  2010-11-18       Impact factor: 2.691

5.  Pathogen evolution and the immunological niche.

Authors:  Sarah Cobey
Journal:  Ann N Y Acad Sci       Date:  2014-07       Impact factor: 5.691

6.  Antibodies of influenza A(H1N1)pdm09 virus in pigs' sera cross-react with other influenza A virus subtypes. A retrospective epidemiological interpretation of Norway's serosurveillance data from 2009-2017.

Authors:  Jwee Chiek Er; Bjørn Lium; Tore Framstad
Journal:  Epidemiol Infect       Date:  2020-03-13       Impact factor: 2.451

7.  A human coronavirus evolves antigenically to escape antibody immunity.

Authors:  Rachel T Eguia; Katharine H D Crawford; Terry Stevens-Ayers; Laurel Kelnhofer-Millevolte; Alexander L Greninger; Janet A Englund; Michael J Boeckh; Jesse D Bloom
Journal:  PLoS Pathog       Date:  2021-04-08       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.